Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines

NCT00838370 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Capecitabine, 5-fluorouracil

Sponsor

The Netherlands Cancer Institute